
PCC reduced early transfusion and chest-tube drainage versus plasma after cardiac surgery, with no detected safety difference
AI-summarized from the linked source. Educational brief, not medical advice.
Brief summary
A meta-analysis of 10 randomized and cohort studies involving 2,643 adults undergoing cardiac surgery found that prothrombin complex concentrate was associated with fewer early red-cell transfusions, less 12- to 24-hour chest-tube drainage, and a shorter hospital stay than fresh frozen plasma, without significant differences in mortality or thromboembolic events.
What NurseJet pulled from the source
This systematic review compared prothrombin complex concentrate (PCC) with fresh frozen plasma for coagulopathic bleeding in adults undergoing cardiac surgery. Across 10 randomized and cohort studies with 2,643 patients, PCC was associated with lower red-cell transfusion requirements during the first 24 hours, about 189 mL less chest-tube drainage from 12 to 24 hours, and a hospital stay shorter by about 1.2 days. The analysis did not detect significant differences in re-exploration, mortality, thromboembolic events, stroke, acute kidney injury, ICU stay, or serious adverse events. Several outcomes had moderate to high heterogeneity, so the absence of a detected safety difference should not be interpreted as proof of equivalent safety.
Why this matters for nurses
Cardiac and critical-care nurses trend chest-tube output, hemodynamics, transfusion exposure, and possible thrombotic or transfusion-related complications after surgery. The review informs surveillance around two provider-directed coagulation strategies.
Bedside takeaway
PCC was linked to less early transfusion and drainage than plasma after cardiac surgery, while mixed-study evidence leaves safety uncertainty.
How This Applies in Practice
Use this when: Monitoring an adult receiving provider-ordered PCC or fresh frozen plasma for bleeding after cardiac surgery.
On your shift
- Verify the ordered product and administration plan, then trend chest-tube output, hemodynamics, laboratory results, and additional transfusion needs.
- Escalate unexpected bleeding, transfusion reactions, neurologic changes, or other possible thrombotic complications through the cardiac-surgery team.
Explain this for my unit
Key takeaways
- The review included 10 randomized and cohort studies with 2,643 adult cardiac-surgery patients.
- PCC was associated with lower early red-cell transfusion use and less 12- to 24-hour chest-tube drainage than plasma.
- Mortality, thromboembolic events, stroke, acute kidney injury, and serious adverse events did not differ significantly.
- Mixed study designs and moderate to high heterogeneity limit certainty for several outcomes.
Practice implications
- When PCC or plasma is ordered for post-cardiac-surgery bleeding, verify the product and administration plan and trend bleeding, chest-tube output, transfusion requirements, hemodynamics, and possible complications. Report unexpected bleeding or thrombotic concerns promptly; do not substitute one product for another from this review alone.
Limitations & cautions
- The analysis combined randomized trials and cohort studies, and several outcomes had moderate to high heterogeneity. Event estimates may be affected by differences in dosing, bleeding definitions, transfusion protocols, and patient risk. Nonsignificant safety outcomes do not establish equivalence, and the authors call for larger high-quality trials.
- AI-summarized from the linked source. Review the original article before applying to practice.
Citations
Exact source links
Public citations are filtered to exact credible source pages. Homepage-only or invalid links stay in admin review and are not shown here.
Journal of cardiothoracic surgery (PubMed)
Journal of cardiothoracic surgery (PubMed). Efficacy and safety of prothrombin complex concentrate versus fresh frozen plasma in adult patients undergoing cardiac surgery: a systematic review and meta-analysis.
https://pubmed.ncbi.nlm.nih.gov/42469870/
Professional education only


